Polycythemia Vera
📧 Sign up to get email alerts when something new happens for Polycythemia Vera.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-01-13Clinical Trial Update: Elotuzumab for the Treatment of JAK2-Mutated Myelofibrosis [Phase 2]
Phase 2 clinical trial evaluating elotuzumab for JAK2-mutated myelofibrosis; the study is active but not recruiting and includes myelofibros…
-
CLINICAL_TRIALS research · 2026-01-09Clinical Trial Update: Ropeginterferon Alfa-2b in Patients With Polycythemia Vera (PV) Without Symptomatic Splenomegaly
A clinical trial evaluating Ropeginterferon Alfa-2b for polycythemia vera patients without symptomatic splenomegaly is currently recruiting.…
-
CLINICAL_TRIALS other · 2026-01-08Clinical Trial Update: Ruxolitinib in Thrombocythemia and Polycythemia Vera [Phase 2]
A Phase 2 trial of ruxolitinib for essential thrombocythemia and polycythemia vera is currently recruiting at Massachusetts General Hospital…
-
CLINICAL_TRIALS research · 2026-01-07Clinical Trial Update: IMG-7289 in Patients With Essential Thrombocythemia (ET) or Polycythemia Vera (PV) [Phase 2]
Phase 2 clinical trial update for IMG-7289 in essential thrombocythemia and polycythemia vera; the study is currently active but not recruit…
-
CLINICAL_TRIALS research · 2025-12-26Clinical Trial Update: Observational Study on the Use of Ropeginterferon Alfa-2b in Polycythemia Vera (ROPEG-PV)
This is an observational update on ropeginterferon alfa-2b for polycythemia vera; the study is active but not recruiting.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-12-26Clinical Trial Update: A ELN-Multicenter Study on Phenotypic Evolution and Clinical Outcomes
A multicenter ELN study investigating phenotypic evolution and clinical outcomes in polycythemia vera and thrombocythemia is currently recru…
-
CLINICAL_TRIALS research · 2025-12-26Clinical Trial Update: LOW-PV Continuation
The LOW-PV Continuation trial (NCT06752941) sponsored by FROM- Fondazione per la Ricerca Ospedale di Bergamo- ETS is currently recruiting fo…
-
CLINICAL_TRIALS research · 2025-12-19Clinical Trial Update: Study to Assess SLN124 in Patients With Polycythemia Vera [Phase 1, Phase 2]
Clinical trial update for SLN124 in Polycythemia vera reports ongoing Phase 1/Phase 2 evaluation. The study is currently active but not recr…
-
CLINICAL_TRIALS research · 2025-12-17Clinical Trial Update: MethoTRExATE in MyelOpRolifErative Neoplasms (TREATMORE) Trial [Phase 2]
A Phase 2 clinical trial called TREATMORE evaluating MethoTRExATE in myeloproliferative neoplasms is currently recruiting for polycythemia v…
-
CLINICAL_TRIALS research · 2025-12-15Clinical Trial Update: Evaluation of Real-World Data on Ropeginterferon Alfa-2b in Patients With Polycythemia Vera: Insights From a Multicenter Study
A multicenter study is evaluating real-world data on ropeginterferon alfa-2b for polycythemia vera, with enrollment not yet started.
-
CLINICAL_TRIALS research · 2025-12-08Clinical Trial Update: Functional and Phenotypic Characterization of Monocytes in Myeloproliferative Syndromes [NA]
A clinical trial is ongoing to characterize monocytes in myeloproliferative neoplasms, with recruitment currently in progress.
-
CLINICAL_TRIALS research · 2025-11-21Clinical Trial Update: Blood Viscosity in Polycythemia Patients
A clinical trial update indicating a study on blood viscosity in primary and secondary polycythemia is currently recruiting.
-
CLINICAL_TRIALS other · 2025-11-18Clinical Trial Update: Managed Access Programs for INC424, Ruxolitinib
Novartis-sponsored update on managed access programs for INC424 (ruxolitinib), outlining eligible indications including primary myelofibrosi…
-
CLINICAL_TRIALS research · 2025-11-18Clinical Trial Update: A Study of Ruxolitinib in Combination With Abemaciclib for the Treatment of Myelofibrosis [Phase 1]
Phase 1 clinical trial evaluating the combination of ruxolitinib and abemaciclib for myelofibrosis (including myelofibrosis associated with …
-
EMA approval · 2025-11-10EMA Authorised: Jakavi (ruxolitinib phosphate) — Novartis Europharm Limited
Jakavi (ruxolitinib phosphate) has been authorised in the EU with indications for polycythemia vera and graft-versus-host disease. The decis…
-
EMA approval · 2025-11-05EMA Authorised: Pegasys (peginterferon alfa-2a) — pharmaand GmbH
EMA authorised Pegasys (peginterferon alfa-2a) for chronic hepatitis C, chronic hepatitis B, polycythemia vera, and essential thrombocythemi…
-
CLINICAL_TRIALS withdrawal · 2025-11-05Clinical Trial Update: MAP to Provide Access to Ruxolitinib, for Patients With Polycythemia Vera
Clinical trial access program for ruxolitinib in polycythemia vera is no longer available.
-
CLINICAL_TRIALS trial_result · 2025-09-19Clinical Trial Update: CO-Rebreathing in Comparison to Isotopic Red Cell Volume Determination in the Diagnosis of Primitive and Secondary Polycythemia [NA]
The study compares CO-rebreathing with isotopic red cell volume measurement for diagnosing primitive and secondary polycythemia; the trial s…
-
CLINICAL_TRIALS trial_result · 2025-09-15Clinical Trial Update: Efficacy and Safety of P1101 in Polycythemia Vera Patients for Whom the Standard of Treatment is Difficult to Apply [Phase 2]
Phase 2 trial evaluating the efficacy and safety of P1101 in polycythemia vera patients with difficult-to-treat standard therapies. Results …
-
CLINICAL_TRIALS research · 2025-09-03Clinical Trial Update: Study to Identify and Describe Predictive Factors for Thromboembolic Events in Patients With High-risk Polycythemia Vera
This ClinicalTrials.gov study sponsored by Novartis seeks to identify predictive factors for thromboembolic events in high-risk polycythemia…
-
CLINICAL_TRIALS research · 2025-08-19Clinical Trial Update: A Study of GLB-001 in Patients With Myeloid Malignancies [Phase 1]
A Phase 1 clinical trial evaluating GLB-001 in patients with myeloid malignancies is currently recruiting.
-
CLINICAL_TRIALS research · 2025-08-13Clinical Trial Update: A Study to Assess Efficacy, Safety, and Tolerability of P1101 in Adult Patients With PV [Phase 3]
This entry reports on a Phase 3 study evaluating P1101 in adults with polycythemia vera. The trial is currently active but not recruiting.
-
CLINICAL_TRIALS trial_result · 2025-08-07Clinical Trial Update: Hepcidin Mimetic in Patients With Polycythemia Vera (REVIVE) [Phase 2]
Phase 2 REVIVE trial evaluating a hepcidin mimetic in polycythemia vera has completed.
-
CLINICAL_TRIALS research · 2025-08-07Clinical Trial Update: A Phase 3 Study of Rusfertide in Patients With Polycythemia Vera [Phase 3]
Phase 3 clinical trial update for rusfertide in patients with polycythemia vera; the study is currently ACTIVE_NOT_RECRUITING.
-
CLINICAL_TRIALS trial_result · 2025-08-06Clinical Trial Update: Study to Evaluate the Long-term Safety of Rusfertide (PTG-300) in Subjects With Polycythemia Vera [Phase 3]
A phase 3 long-term safety study of Rusfertide (PTG-300) in polycythemia vera is active but not recruiting.